Q1 2024 13F Holders as of 31 Mar 2024
-
Type / Class
-
Equity / Ordinary Shares, par value $0.0001 per share (Including Ordinary Shares Underlying American Depository Shares)
-
Shares outstanding
-
264,351,875
-
Total 13F shares
-
12,194,479
-
Share change
-
+211,381
-
Total reported value
-
$22,682,620
-
Put/Call ratio
-
29%
-
Price per share
-
$1.86
-
Number of holders
-
39
-
Value change
-
+$350,985
-
Number of buys
-
15
-
Number of sells
-
19
Institutional Holders of NovaBridge Biosciences - Ordinary Shares, par value $0.0001 per share (Including Ordinary Shares Underlying American Depository Shares) (NBP) as of Q1 2024
As of 31 Mar 2024,
NovaBridge Biosciences - Ordinary Shares, par value $0.0001 per share (Including Ordinary Shares Underlying American Depository Shares) (NBP) was held by
39 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
12,194,479 shares.
The largest 10 holders included
HHLR ADVISORS, LTD., Caligan Partners LP, TWO SIGMA ADVISERS, LP, TWO SIGMA INVESTMENTS, LP, Temasek Holdings (Private) Ltd, GSA CAPITAL PARTNERS LLP, BOOTHBAY FUND MANAGEMENT, LLC, Exome Asset Management LLC, EDBI Pte Ltd, and abrdn plc.
This page lists
38
institutional shareholders reporting positions in this security
for the Q1 2024 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.